🔗 Share this article

A shadow economy for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Experimental Drug Gaining Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing effects. Followers are urged to contact these accounts directly for source information, while also obtaining discount codes.

Active Trade on Messaging Platforms

Separately, a robust trade exists on Telegram, where communities with thousands of participants share comparison photos, injection guides and assertions of next-day UK delivery. Vendors promote the drug there before redirecting buyers to other platforms for transactions.

Understanding Retatrutide

This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Professionals Express Concerns

However, doctors and pharmacists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to individuals injecting products of uncertain source.

Several professionals said the demand for the experimental drug could be linked to the rising price of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to penalties, legal action or imprisonment.

Platform Reaction and Material Elimination

Based on the social media company, the service has removed problematic content and banned associated hashtags and query recommendations. The company said it was committed to maintaining the service secure and investing in strengthening enforcement strategies.

Online Trading Activities

Research also found groups with up to 9,000 members marketing retatrutide using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of members, filled with images of weight loss, positive reviews and step-by-step instructions for preparing or administering at home.

Within minutes of entering one group, a seller posted WhatsApp details, where most transactions take place. The seller provided an guidebook and guaranteed shipping within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, health issues or previous experience.

Product Details and Costs

Within these communities, messages show dark colored parcels with Royal Mail stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with purified liquid, or pre-filled pens typically sold at 160 pounds for 20mg. When questioned how much time a injector should last, sellers give conflicting answers ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A representative for Telegram stated it actively moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting substances they cannot confirm. Although the science behind retatrutide is valid, these digital products may not contain what they claim,” said Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her staff has already encountered patients injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may expose users to potentially serious medical dangers”.